Cybin announces poster presentation at neuroscience 2023 annual meeting

Toronto--(business wire)--cybin inc. (nyse american:cybn) (neo:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced a poster presentation at neuroscience 2023 hosted by the society for neuroscience (“sfn”) taking place november 11-15, 2022, in washington, d.c. “it is always exciting to participate in this annual gathering of.
CYBN Ratings Summary
CYBN Quant Ranking